- Pricing and Access—From IRA to Innovation🔍
- Big Pharma Pricing Is a Racket. These Startups Aim to Disrupt It.🔍
- Trump embraces conspiratorial language to attack Big Pharma🔍
- How Big Pharma Was Captured by the One Percent🔍
- Costs of Drug Development and Research and ...🔍
- Bernie vs. Big Pharma🔍
- Rising Health Care Costs🔍
- Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue ...🔍
Big Pharma Opens 2024 with Hundreds of Price Hikes
Pricing and Access—From IRA to Innovation: 2024 Trends
The truth of, well, pharma has to increase drug prices in order to maintain their margins and still cover the cost of coverage either from ...
Hiltzik: Biden could do what Trump promised on drug prices
The increase levied by AbbVie on its rheumatoid arthritis drug Humira, the best-selling drug in the world, was 7.4%. AbbVie collects revenue of ...
Big Pharma Pricing Is a Racket. These Startups Aim to Disrupt It.
That's because by and large, name-brand medications, not generics, drive high drug costs. While generics comprise 84 percent of the prescription ...
Trump embraces conspiratorial language to attack Big Pharma - Axios
In his first campaign for president, Donald Trump tapped into bipartisan anger over high drug prices to bash pharmaceutical companies.
How Big Pharma Was Captured by the One Percent
“The public expects that drug prices recoup R&D investments based on science and patient needs. But they're shows and aspirational signals for ...
Costs of Drug Development and Research and ... - JAMA Network
High drug prices increase the likelihood of medication nonadherence and are an ongoing public health concern in the US. US drug prices are 2 to ...
Bernie vs. Big Pharma: Senate hearing exposes rift over high drug ...
In his opening statement, Sanders asked the CEOs why their expensive drugs — including J&J's Stelara, Merck's Januvia and BMS' Eliquis — cost ...
Rising Health Care Costs, Surging Prescription Drug Pricing, Acute ...
Soaring U.S. health care costs show little sign of abating in 2024, and concerns about the affordability of medications and medical services ...
Biden: Upcoming drug price cuts a victory over 'Big Pharma'
President Joe Biden touted prescription drug cost enforcement and the industry's voluntary insulin price cuts in a speech Wednesday.
Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue ...
We anticipate only moderate levels of mergers and acquisitions (M&A) in 2024 given healthy revenue growth for Big Pharma, pushback from the ...
Large employers forecast 7.8% hike in health costs next year, thanks ...
This year, the estimated total cost of healthcare per employee is $18,639 — up $1,438 from 2023, the survey found.
Big Pharma spends record millions on lobbying amid pressure to ...
Between May and the end of 2018, “drug companies took 57% fewer price increases on brand drugs compared with the same period in 2017,” Azar said ...
FINAL MASTER PLATFORM - Democrats
We lowered families' health insurance premiums, and we stood up to Big Pharma to lower prescription drug prices. ... hike prices faster than inflation.
The Unbearable Cost of Drug Development: Deloitte Report Shows ...
Deloitte found that the average cost of developing a new drug among the top 20 global biopharmas it studied rose 15% ($298 million) last year, ...
How Big Pharma Makes Healthy People Sick | ENDEVR Documentary
I'm 76 and take no medications at all. 20 years ago the Veteran's Administration had me on all kinds of medications, for depression, PTSD, ...
The Twists and Turns in Biopharma Dealmaking: 2024 Trends
As far as the headwinds involved, they include looming mass patent expirations for Big Pharma flagship medicines; the still-tenuous market and ...
Robert F. Kennedy Jr: Trump's biggest anti-establishment bombshell?
The controversial pick has alarmed public health officials and sent ripples through the pharmaceutical industry, causing stock prices of major ...
World's Top 10 Pharma Companies (By 2023 Revenue) - Xtalks
This growth can be attributed to the rising cost of drugs, with prices for new drugs in the US having increased by 35 percent in 2023 compared ...
New York's Big Pharma battlefield and drug-price wars - Lohud
"Regeneron has yet to make a price increase," said Weinreich, using its adult blindness drug as an example of a medication that has shown ...
AstraZeneca, Roche Intensify New Drug Push, Automakers Sink ...
A BIG OPEN CUT MIND AND REDEVELOPED PLANS FOR THE UNDERGROUND, WE ... IF YOU HIKE UP PRICES, CONSUMER AND LUXURY PRODUCTS, CONSUMERS ...